Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.
|Articles|July 17, 2012
Poll: Does Your Practice Sell Ancillary Products?
Author(s)OBGYN.net Staff
From nutritional supplements to pregnancy support products to spa services, more ObGyn practices--and physicians' offices in general--are turning to ancillary products as additional sources of revenue.
Advertisement
From nutritional supplements to pregnancy support products to spa services, more ObGyn practices--and physicians' offices in general--are turning to ancillary products as additional sources of revenue.
Advertisement
Related to this article
Peter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.
The FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.
Neither maternal MOUD dose nor umbilical cord opioid levels were associated with neonatal opioid withdrawal syndrome severity.
ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.
Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.
This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.
This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Top video interviews from The Menopause Society 2026 Annual Meeting
2
Q&A: Peter Hsin, BS, on perioperative ketamine and early postpartum depression
3
Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule
4
FAQ: Who is a candidate for testosterone therapy in women?
5